FAIR Health Reports Nearly 33% Increase in Opioid Use Disorder Diagnoses Among Commercially Insured Patients from 2022 to 2025
According to FAIR Health's annual update of the Opioid Tracker, commercially insured patients with opioid use disorder diagnoses increased by 32.7% nationally between 2022 and 2025. The rate rose from 449 per 100,000 in 2022 to 596 per 100,000 in 2025. FAIR Health's interactive tool provides state-by-state data on opioid use disorder diagnoses and treatment trends. The report highlights Tennessee as having the highest rate of commercially insured patients receiving treatment for opioid use disorder at 1,551 per 100,000 in 2025. The top procedure code by utilization was alcohol/substance abuse services (39% of claim lines), while G2067—medication-assisted treatment with methadone—had the highest aggregate allowed amount at $243 on average per use. The data also shows a significant increase in nurse practitioners' involvement, growing by 67%, followed by psychiatric nurses and emergency medicine specialists. The majority of patients diagnosed were between ages 41 to 50 (28.1%), with males accounting for 56.1% of cases.
Topics: data analytics FAIR Health opioid use disorder public health tracking